nodes	percent_of_prediction	percent_of_DWPC	metapath
Lurasidone—CYP3A4—Temozolomide—brain cancer	0.126	0.487	CbGbCtD
Lurasidone—CYP3A4—Lomustine—brain cancer	0.107	0.414	CbGbCtD
Lurasidone—HTR2A—choroid plexus—brain cancer	0.0268	0.0715	CbGeAlD
Lurasidone—CYP3A4—Etoposide—brain cancer	0.0259	0.1	CbGbCtD
Lurasidone—HTR7—vein—brain cancer	0.0197	0.0524	CbGeAlD
Lurasidone—HTR7—cranial nerve—brain cancer	0.0155	0.0413	CbGeAlD
Lurasidone—HTR7—pons—brain cancer	0.0153	0.0408	CbGeAlD
Lurasidone—HTR2A—trigeminal nerve—brain cancer	0.0136	0.0362	CbGeAlD
Lurasidone—HTR2A—cerebellar cortex—brain cancer	0.0135	0.036	CbGeAlD
Lurasidone—HTR1A—telencephalic ventricle—brain cancer	0.0132	0.0351	CbGeAlD
Lurasidone—HTR7—telencephalic ventricle—brain cancer	0.0126	0.0336	CbGeAlD
Lurasidone—HTR2A—vein—brain cancer	0.0123	0.0327	CbGeAlD
Lurasidone—DRD2—telencephalic ventricle—brain cancer	0.0119	0.0318	CbGeAlD
Lurasidone—HTR2A—cranial nerve—brain cancer	0.00967	0.0258	CbGeAlD
Lurasidone—HTR2A—pons—brain cancer	0.00956	0.0255	CbGeAlD
Lurasidone—HTR1A—ganglion—brain cancer	0.00821	0.0219	CbGeAlD
Lurasidone—Dysarthria—Lomustine—brain cancer	0.00808	0.0221	CcSEcCtD
Lurasidone—HTR2A—telencephalic ventricle—brain cancer	0.00786	0.0209	CbGeAlD
Lurasidone—HTR7—ganglion—brain cancer	0.00785	0.0209	CbGeAlD
Lurasidone—DRD2—ganglion—brain cancer	0.00742	0.0198	CbGeAlD
Lurasidone—HTR2A—pineal body—brain cancer	0.00682	0.0182	CbGeAlD
Lurasidone—HTR7—endothelium—brain cancer	0.00677	0.018	CbGeAlD
Lurasidone—HTR7—blood vessel—brain cancer	0.00624	0.0166	CbGeAlD
Lurasidone—HTR1A—hindbrain—brain cancer	0.00623	0.0166	CbGeAlD
Lurasidone—HTR7—hindbrain—brain cancer	0.00595	0.0159	CbGeAlD
Lurasidone—Lethargy—Lomustine—brain cancer	0.00566	0.0155	CcSEcCtD
Lurasidone—DRD2—hindbrain—brain cancer	0.00563	0.015	CbGeAlD
Lurasidone—Osteoarthritis—Lomustine—brain cancer	0.00554	0.0152	CcSEcCtD
Lurasidone—Amenorrhoea—Procarbazine—brain cancer	0.00552	0.0151	CcSEcCtD
Lurasidone—Dysarthria—Procarbazine—brain cancer	0.00513	0.014	CcSEcCtD
Lurasidone—HTR2A—ganglion—brain cancer	0.00489	0.013	CbGeAlD
Lurasidone—Deep vein thrombosis—Temozolomide—brain cancer	0.00482	0.0132	CcSEcCtD
Lurasidone—Throat tightness—Etoposide—brain cancer	0.00478	0.0131	CcSEcCtD
Lurasidone—Nightmare—Procarbazine—brain cancer	0.00468	0.0128	CcSEcCtD
Lurasidone—Hypokinesia—Carmustine—brain cancer	0.00449	0.0123	CcSEcCtD
Lurasidone—Amenorrhoea—Hydroxyurea—brain cancer	0.00427	0.0117	CcSEcCtD
Lurasidone—HTR2A—endothelium—brain cancer	0.00422	0.0112	CbGeAlD
Lurasidone—Renal failure—Lomustine—brain cancer	0.0042	0.0115	CcSEcCtD
Lurasidone—Creatinine increased—Hydroxyurea—brain cancer	0.00394	0.0108	CcSEcCtD
Lurasidone—Extrapyramidal disorder—Temozolomide—brain cancer	0.00389	0.0106	CcSEcCtD
Lurasidone—HTR2A—blood vessel—brain cancer	0.00389	0.0104	CbGeAlD
Lurasidone—HTR2A—hindbrain—brain cancer	0.00371	0.00989	CbGeAlD
Lurasidone—Lethargy—Procarbazine—brain cancer	0.00359	0.00982	CcSEcCtD
Lurasidone—HTR1A—brainstem—brain cancer	0.00357	0.00951	CbGeAlD
Lurasidone—HTR7—brainstem—brain cancer	0.00341	0.00909	CbGeAlD
Lurasidone—Breast pain—Temozolomide—brain cancer	0.00336	0.00918	CcSEcCtD
Lurasidone—Amenorrhoea—Temozolomide—brain cancer	0.00334	0.00912	CcSEcCtD
Lurasidone—DRD2—brainstem—brain cancer	0.00323	0.00859	CbGeAlD
Lurasidone—HTR1A—telencephalon—brain cancer	0.00317	0.00844	CbGeAlD
Lurasidone—Gait disturbance—Carmustine—brain cancer	0.00311	0.0085	CcSEcCtD
Lurasidone—Infection—Carboplatin—brain cancer	0.00309	0.00846	CcSEcCtD
Lurasidone—Neck pain—Carmustine—brain cancer	0.00307	0.00839	CcSEcCtD
Lurasidone—Dysphagia—Procarbazine—brain cancer	0.00304	0.00831	CcSEcCtD
Lurasidone—Pulmonary embolism—Carmustine—brain cancer	0.00303	0.00829	CcSEcCtD
Lurasidone—HTR7—telencephalon—brain cancer	0.00303	0.00807	CbGeAlD
Lurasidone—Eosinophilia—Procarbazine—brain cancer	0.00301	0.00823	CcSEcCtD
Lurasidone—Gait disturbance—Temozolomide—brain cancer	0.003	0.00821	CcSEcCtD
Lurasidone—Leukopenia—Lomustine—brain cancer	0.00299	0.00817	CcSEcCtD
Lurasidone—Angina pectoris—Procarbazine—brain cancer	0.00296	0.0081	CcSEcCtD
Lurasidone—Pulmonary embolism—Temozolomide—brain cancer	0.00293	0.00801	CcSEcCtD
Lurasidone—DRD2—telencephalon—brain cancer	0.00286	0.00763	CbGeAlD
Lurasidone—ADRA2C—telencephalon—brain cancer	0.00278	0.00741	CbGeAlD
Lurasidone—Infection—Lomustine—brain cancer	0.00271	0.0074	CcSEcCtD
Lurasidone—Cardiovascular disorder—Etoposide—brain cancer	0.00267	0.0073	CcSEcCtD
Lurasidone—Blood creatinine increased—Hydroxyurea—brain cancer	0.00255	0.00698	CcSEcCtD
Lurasidone—Diabetes mellitus—Carmustine—brain cancer	0.00253	0.00692	CcSEcCtD
Lurasidone—HTR7—gonad—brain cancer	0.00253	0.00673	CbGeAlD
Lurasidone—Breast disorder—Hydroxyurea—brain cancer	0.00246	0.00673	CcSEcCtD
Lurasidone—HTR7—medulla oblongata—brain cancer	0.00238	0.00634	CbGeAlD
Lurasidone—Decreased appetite—Lomustine—brain cancer	0.00237	0.00647	CcSEcCtD
Lurasidone—DRD2—pituitary gland—brain cancer	0.00233	0.00621	CbGeAlD
Lurasidone—Hot flush—Temozolomide—brain cancer	0.00228	0.00622	CcSEcCtD
Lurasidone—HTR1A—midbrain—brain cancer	0.00228	0.00606	CbGeAlD
Lurasidone—ADRA2C—pituitary gland—brain cancer	0.00227	0.00604	CbGeAlD
Lurasidone—Menopausal symptoms—Temozolomide—brain cancer	0.00226	0.00616	CcSEcCtD
Lurasidone—ADRA2A—telencephalon—brain cancer	0.00222	0.00592	CbGeAlD
Lurasidone—HTR1A—spinal cord—brain cancer	0.00222	0.00591	CbGeAlD
Lurasidone—Dysuria—Hydroxyurea—brain cancer	0.0022	0.00602	CcSEcCtD
Lurasidone—Neutropenia—Hydroxyurea—brain cancer	0.0022	0.00602	CcSEcCtD
Lurasidone—ADRA2C—medulla oblongata—brain cancer	0.00219	0.00582	CbGeAlD
Lurasidone—Arrhythmia—Procarbazine—brain cancer	0.00218	0.00595	CcSEcCtD
Lurasidone—HTR7—midbrain—brain cancer	0.00217	0.00579	CbGeAlD
Lurasidone—Weight increased—Hydroxyurea—brain cancer	0.00214	0.00586	CcSEcCtD
Lurasidone—HTR2A—brainstem—brain cancer	0.00213	0.00567	CbGeAlD
Lurasidone—HTR7—spinal cord—brain cancer	0.00212	0.00565	CbGeAlD
Lurasidone—Infestation—Hydroxyurea—brain cancer	0.0021	0.00574	CcSEcCtD
Lurasidone—Infestation NOS—Hydroxyurea—brain cancer	0.0021	0.00574	CcSEcCtD
Lurasidone—DRD2—midbrain—brain cancer	0.00206	0.00548	CbGeAlD
Lurasidone—ADRA2C—midbrain—brain cancer	0.002	0.00532	CbGeAlD
Lurasidone—HTR1A—endocrine gland—brain cancer	0.002	0.00532	CbGeAlD
Lurasidone—Tremor—Procarbazine—brain cancer	0.00199	0.00543	CcSEcCtD
Lurasidone—Hepatobiliary disease—Hydroxyurea—brain cancer	0.00199	0.00543	CcSEcCtD
Lurasidone—HTR1A—head—brain cancer	0.00197	0.00526	CbGeAlD
Lurasidone—Anaemia—Procarbazine—brain cancer	0.00196	0.00535	CcSEcCtD
Lurasidone—ADRA2C—spinal cord—brain cancer	0.00195	0.00519	CbGeAlD
Lurasidone—Breast disorder—Temozolomide—brain cancer	0.00192	0.00526	CcSEcCtD
Lurasidone—HTR7—endocrine gland—brain cancer	0.00191	0.00509	CbGeAlD
Lurasidone—Dysphagia—Carmustine—brain cancer	0.0019	0.0052	CcSEcCtD
Lurasidone—Syncope—Procarbazine—brain cancer	0.0019	0.0052	CcSEcCtD
Lurasidone—Leukopenia—Procarbazine—brain cancer	0.0019	0.00519	CcSEcCtD
Lurasidone—HTR2A—telencephalon—brain cancer	0.00189	0.00503	CbGeAlD
Lurasidone—HTR7—head—brain cancer	0.00189	0.00502	CbGeAlD
Lurasidone—Alanine aminotransferase increased—Temozolomide—brain cancer	0.00188	0.00513	CcSEcCtD
Lurasidone—Loss of consciousness—Procarbazine—brain cancer	0.00186	0.00509	CcSEcCtD
Lurasidone—ADRA2A—gonad—brain cancer	0.00185	0.00494	CbGeAlD
Lurasidone—Dysphagia—Temozolomide—brain cancer	0.00184	0.00503	CcSEcCtD
Lurasidone—Convulsion—Procarbazine—brain cancer	0.00184	0.00502	CcSEcCtD
Lurasidone—Hypertension—Procarbazine—brain cancer	0.00183	0.005	CcSEcCtD
Lurasidone—ADRA2A—pituitary gland—brain cancer	0.00181	0.00482	CbGeAlD
Lurasidone—DRD2—endocrine gland—brain cancer	0.00181	0.00481	CbGeAlD
Lurasidone—Myalgia—Procarbazine—brain cancer	0.0018	0.00493	CcSEcCtD
Lurasidone—HTR1A—central nervous system—brain cancer	0.0018	0.0048	CbGeAlD
Lurasidone—Anxiety—Procarbazine—brain cancer	0.0018	0.00492	CcSEcCtD
Lurasidone—DRD2—head—brain cancer	0.00178	0.00475	CbGeAlD
Lurasidone—Neutropenia—Carmustine—brain cancer	0.00178	0.00486	CcSEcCtD
Lurasidone—Dry mouth—Procarbazine—brain cancer	0.00177	0.00482	CcSEcCtD
Lurasidone—HTR1A—cerebellum—brain cancer	0.00176	0.00469	CbGeAlD
Lurasidone—ADRA2A—medulla oblongata—brain cancer	0.00174	0.00465	CbGeAlD
Lurasidone—ADRA2C—head—brain cancer	0.00173	0.00462	CbGeAlD
Lurasidone—Vomiting—Lomustine—brain cancer	0.00173	0.00474	CcSEcCtD
Lurasidone—HTR7—central nervous system—brain cancer	0.00172	0.00458	CbGeAlD
Lurasidone—Dysuria—Temozolomide—brain cancer	0.00172	0.0047	CcSEcCtD
Lurasidone—Neutropenia—Temozolomide—brain cancer	0.00172	0.0047	CcSEcCtD
Lurasidone—Infection—Procarbazine—brain cancer	0.00172	0.0047	CcSEcCtD
Lurasidone—Hyperglycaemia—Carmustine—brain cancer	0.00172	0.00469	CcSEcCtD
Lurasidone—Angiopathy—Hydroxyurea—brain cancer	0.00171	0.00467	CcSEcCtD
Lurasidone—Shock—Procarbazine—brain cancer	0.0017	0.00465	CcSEcCtD
Lurasidone—Erectile dysfunction—Temozolomide—brain cancer	0.00169	0.00463	CcSEcCtD
Lurasidone—Tachycardia—Procarbazine—brain cancer	0.00169	0.00461	CcSEcCtD
Lurasidone—HTR7—cerebellum—brain cancer	0.00168	0.00448	CbGeAlD
Lurasidone—Weight increased—Temozolomide—brain cancer	0.00167	0.00458	CcSEcCtD
Lurasidone—Hyperhidrosis—Procarbazine—brain cancer	0.00167	0.00457	CcSEcCtD
Lurasidone—Renal failure—Carmustine—brain cancer	0.00167	0.00456	CcSEcCtD
Lurasidone—Hyperglycaemia—Temozolomide—brain cancer	0.00166	0.00453	CcSEcCtD
Lurasidone—Urinary tract infection—Carmustine—brain cancer	0.00165	0.00451	CcSEcCtD
Lurasidone—Infestation—Temozolomide—brain cancer	0.00164	0.00448	CcSEcCtD
Lurasidone—Infestation NOS—Temozolomide—brain cancer	0.00164	0.00448	CcSEcCtD
Lurasidone—DRD2—central nervous system—brain cancer	0.00163	0.00433	CbGeAlD
Lurasidone—Nausea—Lomustine—brain cancer	0.00162	0.00442	CcSEcCtD
Lurasidone—Hypotension—Procarbazine—brain cancer	0.00162	0.00442	CcSEcCtD
Lurasidone—ADRA2A—midbrain—brain cancer	0.00159	0.00425	CbGeAlD
Lurasidone—Urinary tract infection—Temozolomide—brain cancer	0.00159	0.00436	CcSEcCtD
Lurasidone—DRD2—cerebellum—brain cancer	0.00159	0.00424	CbGeAlD
Lurasidone—ADRA2C—central nervous system—brain cancer	0.00158	0.00421	CbGeAlD
Lurasidone—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00158	0.00431	CcSEcCtD
Lurasidone—HTR2A—gonad—brain cancer	0.00158	0.0042	CbGeAlD
Lurasidone—Insomnia—Procarbazine—brain cancer	0.00156	0.00428	CcSEcCtD
Lurasidone—ADRA2A—spinal cord—brain cancer	0.00156	0.00414	CbGeAlD
Lurasidone—Hepatobiliary disease—Temozolomide—brain cancer	0.00155	0.00424	CcSEcCtD
Lurasidone—ADRA2C—cerebellum—brain cancer	0.00155	0.00412	CbGeAlD
Lurasidone—Somnolence—Procarbazine—brain cancer	0.00154	0.0042	CcSEcCtD
Lurasidone—HTR2A—pituitary gland—brain cancer	0.00154	0.0041	CbGeAlD
Lurasidone—Anaemia—Hydroxyurea—brain cancer	0.00152	0.00414	CcSEcCtD
Lurasidone—Decreased appetite—Procarbazine—brain cancer	0.0015	0.00411	CcSEcCtD
Lurasidone—Alanine aminotransferase increased—Etoposide—brain cancer	0.0015	0.00411	CcSEcCtD
Lurasidone—Connective tissue disorder—Carmustine—brain cancer	0.0015	0.00409	CcSEcCtD
Lurasidone—Fatigue—Procarbazine—brain cancer	0.00149	0.00408	CcSEcCtD
Lurasidone—HTR2A—medulla oblongata—brain cancer	0.00148	0.00395	CbGeAlD
Lurasidone—Malaise—Hydroxyurea—brain cancer	0.00148	0.00404	CcSEcCtD
Lurasidone—Dysphagia—Etoposide—brain cancer	0.00147	0.00402	CcSEcCtD
Lurasidone—Leukopenia—Hydroxyurea—brain cancer	0.00147	0.00401	CcSEcCtD
Lurasidone—Urinary tract disorder—Temozolomide—brain cancer	0.00145	0.00397	CcSEcCtD
Lurasidone—Connective tissue disorder—Temozolomide—brain cancer	0.00145	0.00395	CcSEcCtD
Lurasidone—Urethral disorder—Temozolomide—brain cancer	0.00144	0.00394	CcSEcCtD
Lurasidone—HTR1A—brain—brain cancer	0.00143	0.00381	CbGeAlD
Lurasidone—Eye disorder—Carmustine—brain cancer	0.00142	0.00389	CcSEcCtD
Lurasidone—Convulsion—Hydroxyurea—brain cancer	0.00142	0.00388	CcSEcCtD
Lurasidone—Gastrointestinal pain—Procarbazine—brain cancer	0.00141	0.00387	CcSEcCtD
Lurasidone—ADRA2A—endocrine gland—brain cancer	0.0014	0.00373	CbGeAlD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00139	0.00379	CcSEcCtD
Lurasidone—ADRA2A—head—brain cancer	0.00138	0.00368	CbGeAlD
Lurasidone—Neutropenia—Etoposide—brain cancer	0.00138	0.00376	CcSEcCtD
Lurasidone—Eye disorder—Temozolomide—brain cancer	0.00138	0.00376	CcSEcCtD
Lurasidone—Abdominal pain—Procarbazine—brain cancer	0.00137	0.00374	CcSEcCtD
Lurasidone—Cardiac disorder—Temozolomide—brain cancer	0.00137	0.00373	CcSEcCtD
Lurasidone—HTR7—brain—brain cancer	0.00137	0.00364	CbGeAlD
Lurasidone—Arrhythmia—Carmustine—brain cancer	0.00136	0.00372	CcSEcCtD
Lurasidone—HTR2A—midbrain—brain cancer	0.00136	0.00361	CbGeAlD
Lurasidone—Angiopathy—Temozolomide—brain cancer	0.00134	0.00365	CcSEcCtD
Lurasidone—Mental disorder—Carmustine—brain cancer	0.00133	0.00365	CcSEcCtD
Lurasidone—Infection—Hydroxyurea—brain cancer	0.00133	0.00364	CcSEcCtD
Lurasidone—Malnutrition—Carmustine—brain cancer	0.00133	0.00362	CcSEcCtD
Lurasidone—HTR2A—spinal cord—brain cancer	0.00132	0.00352	CbGeAlD
Lurasidone—Nervous system disorder—Hydroxyurea—brain cancer	0.00131	0.00359	CcSEcCtD
Lurasidone—Infestation—Etoposide—brain cancer	0.00131	0.00359	CcSEcCtD
Lurasidone—Infestation NOS—Etoposide—brain cancer	0.00131	0.00359	CcSEcCtD
Lurasidone—Skin disorder—Hydroxyurea—brain cancer	0.0013	0.00355	CcSEcCtD
Lurasidone—DRD2—brain—brain cancer	0.00129	0.00344	CbGeAlD
Lurasidone—Renal failure—Etoposide—brain cancer	0.00129	0.00353	CcSEcCtD
Lurasidone—Mental disorder—Temozolomide—brain cancer	0.00129	0.00353	CcSEcCtD
Lurasidone—Back pain—Carmustine—brain cancer	0.00128	0.00351	CcSEcCtD
Lurasidone—Malnutrition—Temozolomide—brain cancer	0.00128	0.0035	CcSEcCtD
Lurasidone—ADRA2A—central nervous system—brain cancer	0.00126	0.00336	CbGeAlD
Lurasidone—ADRA2C—brain—brain cancer	0.00126	0.00335	CbGeAlD
Lurasidone—Vision blurred—Carmustine—brain cancer	0.00125	0.00342	CcSEcCtD
Lurasidone—Tremor—Carmustine—brain cancer	0.00124	0.0034	CcSEcCtD
Lurasidone—Asthenia—Procarbazine—brain cancer	0.00124	0.00339	CcSEcCtD
Lurasidone—Hepatobiliary disease—Etoposide—brain cancer	0.00124	0.00339	CcSEcCtD
Lurasidone—Back pain—Temozolomide—brain cancer	0.00124	0.00339	CcSEcCtD
Lurasidone—ADRA2A—cerebellum—brain cancer	0.00123	0.00329	CbGeAlD
Lurasidone—Anaemia—Carmustine—brain cancer	0.00123	0.00335	CcSEcCtD
Lurasidone—Agranulocytosis—Etoposide—brain cancer	0.00122	0.00335	CcSEcCtD
Lurasidone—Pruritus—Procarbazine—brain cancer	0.00122	0.00335	CcSEcCtD
Lurasidone—Agitation—Carmustine—brain cancer	0.00122	0.00333	CcSEcCtD
Lurasidone—Vision blurred—Temozolomide—brain cancer	0.00121	0.0033	CcSEcCtD
Lurasidone—Tremor—Temozolomide—brain cancer	0.0012	0.00328	CcSEcCtD
Lurasidone—Dyspnoea—Hydroxyurea—brain cancer	0.00119	0.00326	CcSEcCtD
Lurasidone—HTR2A—endocrine gland—brain cancer	0.00119	0.00317	CbGeAlD
Lurasidone—Somnolence—Hydroxyurea—brain cancer	0.00119	0.00325	CcSEcCtD
Lurasidone—Leukopenia—Carmustine—brain cancer	0.00119	0.00324	CcSEcCtD
Lurasidone—Anaemia—Temozolomide—brain cancer	0.00118	0.00324	CcSEcCtD
Lurasidone—Diarrhoea—Procarbazine—brain cancer	0.00118	0.00324	CcSEcCtD
Lurasidone—Dyspepsia—Hydroxyurea—brain cancer	0.00118	0.00322	CcSEcCtD
Lurasidone—Agitation—Temozolomide—brain cancer	0.00118	0.00322	CcSEcCtD
Lurasidone—HTR2A—head—brain cancer	0.00118	0.00313	CbGeAlD
Lurasidone—Angioedema—Temozolomide—brain cancer	0.00117	0.0032	CcSEcCtD
Lurasidone—Decreased appetite—Hydroxyurea—brain cancer	0.00116	0.00318	CcSEcCtD
Lurasidone—Urinary tract disorder—Etoposide—brain cancer	0.00116	0.00318	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00116	0.00316	CcSEcCtD
Lurasidone—Malaise—Temozolomide—brain cancer	0.00116	0.00316	CcSEcCtD
Lurasidone—Urethral disorder—Etoposide—brain cancer	0.00115	0.00316	CcSEcCtD
Lurasidone—Fatigue—Hydroxyurea—brain cancer	0.00115	0.00315	CcSEcCtD
Lurasidone—Vertigo—Temozolomide—brain cancer	0.00115	0.00315	CcSEcCtD
Lurasidone—Convulsion—Carmustine—brain cancer	0.00115	0.00314	CcSEcCtD
Lurasidone—Leukopenia—Temozolomide—brain cancer	0.00115	0.00314	CcSEcCtD
Lurasidone—Hypertension—Carmustine—brain cancer	0.00115	0.00313	CcSEcCtD
Lurasidone—Dizziness—Procarbazine—brain cancer	0.00114	0.00313	CcSEcCtD
Lurasidone—Myalgia—Carmustine—brain cancer	0.00113	0.00309	CcSEcCtD
Lurasidone—Anxiety—Carmustine—brain cancer	0.00113	0.00308	CcSEcCtD
Lurasidone—Convulsion—Temozolomide—brain cancer	0.00111	0.00303	CcSEcCtD
Lurasidone—Hypertension—Temozolomide—brain cancer	0.00111	0.00302	CcSEcCtD
Lurasidone—CYP3A4—endocrine gland—brain cancer	0.0011	0.00294	CbGeAlD
Lurasidone—Eye disorder—Etoposide—brain cancer	0.0011	0.00301	CcSEcCtD
Lurasidone—Vomiting—Procarbazine—brain cancer	0.0011	0.00301	CcSEcCtD
Lurasidone—Cardiac disorder—Etoposide—brain cancer	0.00109	0.00299	CcSEcCtD
Lurasidone—Myalgia—Temozolomide—brain cancer	0.00109	0.00298	CcSEcCtD
Lurasidone—Rash—Procarbazine—brain cancer	0.00109	0.00298	CcSEcCtD
Lurasidone—Dermatitis—Procarbazine—brain cancer	0.00109	0.00298	CcSEcCtD
Lurasidone—Anxiety—Temozolomide—brain cancer	0.00109	0.00297	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00108	0.00296	CcSEcCtD
Lurasidone—Infection—Carmustine—brain cancer	0.00108	0.00294	CcSEcCtD
Lurasidone—HTR2A—central nervous system—brain cancer	0.00107	0.00286	CbGeAlD
Lurasidone—Angiopathy—Etoposide—brain cancer	0.00107	0.00292	CcSEcCtD
Lurasidone—Dry mouth—Temozolomide—brain cancer	0.00107	0.00292	CcSEcCtD
Lurasidone—Tachycardia—Carmustine—brain cancer	0.00106	0.00289	CcSEcCtD
Lurasidone—HTR2A—cerebellum—brain cancer	0.00105	0.00279	CbGeAlD
Lurasidone—Infection—Temozolomide—brain cancer	0.00104	0.00284	CcSEcCtD
Lurasidone—Nausea—Procarbazine—brain cancer	0.00103	0.00281	CcSEcCtD
Lurasidone—Nervous system disorder—Temozolomide—brain cancer	0.00103	0.0028	CcSEcCtD
Lurasidone—Skin disorder—Temozolomide—brain cancer	0.00102	0.00278	CcSEcCtD
Lurasidone—Hypotension—Carmustine—brain cancer	0.00101	0.00276	CcSEcCtD
Lurasidone—Hyperhidrosis—Temozolomide—brain cancer	0.00101	0.00276	CcSEcCtD
Lurasidone—ADRA2A—brain—brain cancer	0.001	0.00267	CbGeAlD
Lurasidone—CYP3A4—central nervous system—brain cancer	0.000993	0.00265	CbGeAlD
Lurasidone—Back pain—Etoposide—brain cancer	0.000992	0.00271	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Carmustine—brain cancer	0.000986	0.0027	CcSEcCtD
Lurasidone—Muscle spasms—Etoposide—brain cancer	0.000986	0.00269	CcSEcCtD
Lurasidone—Insomnia—Carmustine—brain cancer	0.000979	0.00268	CcSEcCtD
Lurasidone—Dyspnoea—Carmustine—brain cancer	0.000965	0.00264	CcSEcCtD
Lurasidone—Somnolence—Carmustine—brain cancer	0.000962	0.00263	CcSEcCtD
Lurasidone—Asthenia—Hydroxyurea—brain cancer	0.000961	0.00263	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000953	0.0026	CcSEcCtD
Lurasidone—Anaemia—Etoposide—brain cancer	0.000948	0.00259	CcSEcCtD
Lurasidone—Insomnia—Temozolomide—brain cancer	0.000946	0.00259	CcSEcCtD
Lurasidone—Decreased appetite—Carmustine—brain cancer	0.000941	0.00257	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Carmustine—brain cancer	0.000935	0.00255	CcSEcCtD
Lurasidone—Dyspnoea—Temozolomide—brain cancer	0.000933	0.00255	CcSEcCtD
Lurasidone—Somnolence—Temozolomide—brain cancer	0.00093	0.00254	CcSEcCtD
Lurasidone—Malaise—Etoposide—brain cancer	0.000925	0.00253	CcSEcCtD
Lurasidone—Vertigo—Etoposide—brain cancer	0.000921	0.00252	CcSEcCtD
Lurasidone—Dyspepsia—Temozolomide—brain cancer	0.000921	0.00252	CcSEcCtD
Lurasidone—Leukopenia—Etoposide—brain cancer	0.000918	0.00251	CcSEcCtD
Lurasidone—Diarrhoea—Hydroxyurea—brain cancer	0.000916	0.0025	CcSEcCtD
Lurasidone—Decreased appetite—Temozolomide—brain cancer	0.000909	0.00249	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Temozolomide—brain cancer	0.000903	0.00247	CcSEcCtD
Lurasidone—Fatigue—Temozolomide—brain cancer	0.000902	0.00246	CcSEcCtD
Lurasidone—Loss of consciousness—Etoposide—brain cancer	0.000901	0.00246	CcSEcCtD
Lurasidone—Convulsion—Etoposide—brain cancer	0.000889	0.00243	CcSEcCtD
Lurasidone—Hypertension—Etoposide—brain cancer	0.000885	0.00242	CcSEcCtD
Lurasidone—Dizziness—Hydroxyurea—brain cancer	0.000885	0.00242	CcSEcCtD
Lurasidone—Gastrointestinal pain—Carmustine—brain cancer	0.000885	0.00242	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000867	0.00237	CcSEcCtD
Lurasidone—Abdominal pain—Carmustine—brain cancer	0.000856	0.00234	CcSEcCtD
Lurasidone—Gastrointestinal pain—Temozolomide—brain cancer	0.000855	0.00234	CcSEcCtD
Lurasidone—HTR2A—brain—brain cancer	0.000852	0.00227	CbGeAlD
Lurasidone—Vomiting—Hydroxyurea—brain cancer	0.000851	0.00233	CcSEcCtD
Lurasidone—Rash—Hydroxyurea—brain cancer	0.000844	0.00231	CcSEcCtD
Lurasidone—Dermatitis—Hydroxyurea—brain cancer	0.000843	0.00231	CcSEcCtD
Lurasidone—Infection—Etoposide—brain cancer	0.000832	0.00227	CcSEcCtD
Lurasidone—Abdominal pain—Temozolomide—brain cancer	0.000827	0.00226	CcSEcCtD
Lurasidone—Tachycardia—Etoposide—brain cancer	0.000817	0.00223	CcSEcCtD
Lurasidone—Skin disorder—Etoposide—brain cancer	0.000813	0.00222	CcSEcCtD
Lurasidone—Hyperhidrosis—Etoposide—brain cancer	0.000809	0.00221	CcSEcCtD
Lurasidone—Nausea—Hydroxyurea—brain cancer	0.000795	0.00217	CcSEcCtD
Lurasidone—Hypotension—Etoposide—brain cancer	0.000782	0.00214	CcSEcCtD
Lurasidone—Asthenia—Carmustine—brain cancer	0.000777	0.00212	CcSEcCtD
Lurasidone—Asthenia—Temozolomide—brain cancer	0.000751	0.00205	CcSEcCtD
Lurasidone—Dyspnoea—Etoposide—brain cancer	0.000746	0.00204	CcSEcCtD
Lurasidone—Somnolence—Etoposide—brain cancer	0.000744	0.00203	CcSEcCtD
Lurasidone—Diarrhoea—Carmustine—brain cancer	0.000741	0.00202	CcSEcCtD
Lurasidone—Pruritus—Temozolomide—brain cancer	0.00074	0.00202	CcSEcCtD
Lurasidone—Decreased appetite—Etoposide—brain cancer	0.000728	0.00199	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Etoposide—brain cancer	0.000723	0.00197	CcSEcCtD
Lurasidone—Fatigue—Etoposide—brain cancer	0.000722	0.00197	CcSEcCtD
Lurasidone—Dizziness—Carmustine—brain cancer	0.000716	0.00196	CcSEcCtD
Lurasidone—Diarrhoea—Temozolomide—brain cancer	0.000716	0.00196	CcSEcCtD
Lurasidone—Dizziness—Temozolomide—brain cancer	0.000692	0.00189	CcSEcCtD
Lurasidone—Vomiting—Carmustine—brain cancer	0.000688	0.00188	CcSEcCtD
Lurasidone—Gastrointestinal pain—Etoposide—brain cancer	0.000684	0.00187	CcSEcCtD
Lurasidone—Rash—Carmustine—brain cancer	0.000682	0.00187	CcSEcCtD
Lurasidone—Dermatitis—Carmustine—brain cancer	0.000682	0.00186	CcSEcCtD
Lurasidone—Vomiting—Temozolomide—brain cancer	0.000665	0.00182	CcSEcCtD
Lurasidone—Abdominal pain—Etoposide—brain cancer	0.000662	0.00181	CcSEcCtD
Lurasidone—Rash—Temozolomide—brain cancer	0.00066	0.0018	CcSEcCtD
Lurasidone—Dermatitis—Temozolomide—brain cancer	0.000659	0.0018	CcSEcCtD
Lurasidone—Nausea—Carmustine—brain cancer	0.000643	0.00176	CcSEcCtD
Lurasidone—Nausea—Temozolomide—brain cancer	0.000621	0.0017	CcSEcCtD
Lurasidone—Asthenia—Etoposide—brain cancer	0.000601	0.00164	CcSEcCtD
Lurasidone—Pruritus—Etoposide—brain cancer	0.000592	0.00162	CcSEcCtD
Lurasidone—Diarrhoea—Etoposide—brain cancer	0.000573	0.00157	CcSEcCtD
Lurasidone—Dizziness—Etoposide—brain cancer	0.000554	0.00151	CcSEcCtD
Lurasidone—Vomiting—Etoposide—brain cancer	0.000532	0.00145	CcSEcCtD
Lurasidone—Rash—Etoposide—brain cancer	0.000528	0.00144	CcSEcCtD
Lurasidone—Dermatitis—Etoposide—brain cancer	0.000527	0.00144	CcSEcCtD
Lurasidone—Nausea—Etoposide—brain cancer	0.000497	0.00136	CcSEcCtD
